Evidence map›Paper›PMID 41993976›Full record

ArticleFrontiers in endocrinology2026

Atherogenic index of plasma and cardiovascular high-risk status in the ChinaHEART luohe cohort: multivariable association modeling with nonlinear dose-response and effect heterogeneity.

Jing Bai, Jirui Cai, Zhiwei Huang, Jin Wang, Bing He, Li Guo, Li Wu, Dongliang Liu, Guirang Zhao, Qiaotao Xie and 1 more

Abstract read
In one paragraph

Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jing Bai *Luohe Central Hospital, Luohe Medical College, Luohe, China.
Jirui Cai *Luohe Central Hospital, Luohe Medical College, Luohe, China.
Zhiwei HuangHenan University College of Medicine, Henan University, Kaifeng, China.
Jin WangLuohe Central Hospital, Luohe Medical College, Luohe, China.
Bing HeLuohe Central Hospital, Luohe Medical College, Luohe, China.
Li GuoLuohe Central Hospital, Luohe Medical College, Luohe, China.
Li WuLuohe Central Hospital, Luohe Medical College, Luohe, China.
Dongliang LiuLuohe Central Hospital, Luohe Medical College, Luohe, China.
Guirang ZhaoLuohe Center for Disease Control and Prevention, Luohe, China.
Qiaotao XieLuohe Central Hospital, Luohe Medical College, Luohe, China.
Haoran WangLuohe Central Hospital, Luohe Medical College, Luohe, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Community screening programs increasingly use World Health Organization (WHO) cardiovascular disease (CVD) risk charts to identify individuals at high predicted 10-year risk. The atherogenic index of plasma (AIP), derived from triglycerides (TG) and high-density lipoprotein cholesterol (HDL-C), may capture atherogenic dyslipidemia and support pragmatic risk stratification. Methods: We conducted a cross-sectional analysis of baseline data from the China Health Evaluation And risk Reduction through nationwide Teamwork (ChinaHEART) community screening program in Luohe, China. Among 6,860 screened participants, 6,702 with complete data for AIP computation, WHO risk classification, and prespecified covariates were included. The outcome was the WHO CVD risk chart-defined predicted 10-year CVD high-risk category (high risk: ≥20%), rather than adjudicated or incident CVD events. AIP was calculated as log10(TG [mmol/L]/HDL-C [mmol/L]) and modeled as both a continuous and categorical exposure; spline models tested nonlinearity, and ROC analyses evaluated discrimination and derived a Youden-index cutoff. In addition, we performed an explainable machine-learning pipeline for CVD high-risk prediction using LASSO logistic regression for feature selection (AIP forced-in), followed by a random forest classifier and SHAP-based interpretation. Results: Of 6,860 screened participants, 6,702 were included in the analytic sample (median age 58 years; 38% men). The WHO CVD risk chart-defined predicted 10-year CVD high-risk category was present in 1,440 (21%) participants and was more frequent in the high-AIP group than in the low-AIP group. Higher AIP was associated with higher odds of CVD high-risk status. Restricted cubic splines supported a non-linear association. Discrimination was modest for AIP alone (AUC 0.557) and improved in adjusted models (AUC 0.650). In the machine-learning pipeline (LASSO + random forest), the random forest model achieved an AUC of 0.792, and SHAP analyses ranked LDL-C and history of hypertension as the strongest contributors, with AIP remaining among the top predictive features. Conclusion: In this community-based ChinaHEART population, higher AIP was non-linearly associated with the WHO CVD risk chart-defined predicted 10-year CVD high-risk category. Although AIP alone had limited discrimination, it may serve as a simple adjunct marker to triage individuals for intensified risk assessment in primary-care screening settings.

Indexed as

AtherosclerosisCardiovascular DiseasesCholesterol, HDLTriglyceridesAgedChinaCross-Sectional StudiesFemaleHeart Disease Risk FactorsHumansMaleMiddle AgedRisk AssessmentRisk FactorsCholesterol, HDLTriglyceridesatherogenic dyslipidemiaatherogenic index of plasmacardiovascular disease riskChinaHEARTcommunity screeningWHO CVD risk charts

Identifiers

PMID41993976
PMCPMC13079028

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.